Literature DB >> 34567920

Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study.

Masahiro Ohira1, Yasuhiro Watanabe1, Takashi Yamaguchi1, Atsuhito Saiki1, Shoko Nakamura1, Shou Tanaka1, Naomi Shimizu1, Taiki Nabekura2, Takashi Oshiro2, Ichiro Tatsuno1.   

Abstract

OBJECTIVE: Bariatric surgery (BS) improves glycemic control in type 2 diabetes; however, some patients show insufficient improvement. Understanding the pathophysiology of type 2 diabetes in obese patients can facilitate appropriate treatment for type 2 diabetes after BS. The homeostatic model assessment (HOMA) 2 enables the calculation of the values from C-peptide data and evaluation of insulin users. We aimed to evaluate the pathophysiology of type 2 diabetes using pre- and postoperative parameters and HOMA2 in obese patients who underwent BS.
METHODS: We retrospectively reviewed data from 45 obese patients with type 2 diabetes who underwent BS. They were followed-up for 12 months. The relationship between the HOMA2 score and complete remission (CR) of type 2 diabetes after BS was analyzed. Patients with and without CR were assigned to the CR and non-CR groups, respectively. Multiple regression analysis was used to identify factors associated with improvement in type 2 diabetes after BS.
RESULTS: BS significantly improved body weight and glucose metabolism. The preoperative glycosylated hemoglobin A1c level and insulin secretion (HOMA2-%B) significantly differed between the CR and non-CR groups. Postoperative weight reduction and improved insulin sensitivity correlated significantly with CR; multiple regression showed that the preoperative HOMA 2-%B independently predicted CR of type 2 diabetes after BS.
CONCLUSION: Preoperative insulin secretion, improvement in insulin sensitivity, and weight reduction after BS are related to CR of type 2 diabetes after BS. The results better reveal the pathophysiology of and treatment for type 2 diabetes in obese patients who undergo BS. © The Japan Diabetes Society 2021.

Entities:  

Keywords:  Bariatric surgery; Insulin secretion; Insulin sensitivity; Total weight loss; Type 2 diabetes

Year:  2021        PMID: 34567920      PMCID: PMC8413414          DOI: 10.1007/s13340-021-00493-7

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  38 in total

1.  Evaluation of insulin resistance improvement after laparoscopic sleeve gastrectomy or gastric bypass surgery with HOMA-IR.

Authors:  Yubing Zhu; Zhipeng Sun; Yanmin Du; Guangzhong Xu; Ke Gong; Bin Zhu; Nengwei Zhang
Journal:  Biosci Trends       Date:  2017       Impact factor: 2.400

2.  Predictors of long-term diabetes remission after metabolic surgery.

Authors:  Ming Hsien Lee; Wei-Jei Lee; Keong Chong; Jung-Chien Chen; Kong-Han Ser; Yi-Chih Lee; Shu-Chun Chen
Journal:  J Gastrointest Surg       Date:  2015-04-04       Impact factor: 3.452

3.  Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population.

Authors:  F Genske; J-P Kühn; M Pietzner; G Homuth; W Rathmann; H J Grabe; H Völzke; H Wallaschofski; N Friedrich
Journal:  Int J Obes (Lond)       Date:  2017-08-14       Impact factor: 5.095

4.  C-peptide predicts the remission of type 2 diabetes after bariatric surgery.

Authors:  Wei-Jei Lee; Keong Chong; Kong-Han Ser; Jung-Chien Chen; Yi-Chih Lee; Shu-Chun Chen; Yen-How Su; Min-Han Tsai
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

5.  Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.

Authors:  Atsuhito Saiki; Tomokazu Oyama; Kei Endo; Mariko Ebisuno; Masahiro Ohira; Nobukiyo Koide; Takeyoshi Murano; Yoh Miyashita; Kohji Shirai
Journal:  Diabetes Res Clin Pract       Date:  2006-09-07       Impact factor: 5.602

6.  The effect of weight loss after gastric bypass on C-reactive protein levels.

Authors:  Stanley M Zagorski; Nicole N Papa; Mathew H Chung
Journal:  Surg Obes Relat Dis       Date:  2005 Mar-Apr       Impact factor: 4.734

7.  Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.

Authors:  Ji Yeon Park; Yong Jin Kim
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

Review 8.  Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery.

Authors:  Belén Pérez-Pevida; Javier Escalada; Alexander D Miras; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-19       Impact factor: 5.555

9.  Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme.

Authors:  Chantal Mathieu; Stefano Del Prato; Fady T Botros; Vivian T Thieu; Imre Pavo; Nan Jia; Axel Haupt; Chrisanthi A Karanikas; Luis-Emilio García-Pérez
Journal:  Diabetes Obes Metab       Date:  2018-05-02       Impact factor: 6.577

10.  Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m2 but lower than 32.5 kg/m2.

Authors:  Ying-Xu Li; Deng-Hua Fang; Tian-Xi Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more
  2 in total

1.  Preoperative Plasma Aldosterone Predicts Complete Remission of Type 2 Diabetes after Bariatric Surgery.

Authors:  Masahiro Ohira; Kazuki Abe; Takashi Yamaguchi; Hiroki Onda; Shuhei Yamaoka; Shoko Nakamura; Shou Tanaka; Yasuhiro Watanabe; Taiki Nabekura; Takashi Oshiro; Daiji Nagayama; Atsuhito Saiki; Ichiro Tatsuno
Journal:  Obes Facts       Date:  2022-01-11       Impact factor: 4.807

2.  Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity.

Authors:  Akira Sasaki; Koutaro Yokote; Takeshi Naitoh; Junji Fujikura; Karin Hayashi; Yushi Hirota; Nobuya Inagaki; Yasushi Ishigaki; Kazunori Kasama; Eri Kikkawa; Hidenori Koyama; Hiroaki Masuzaki; Takeshi Miyatsuka; Takehiro Nozaki; Wataru Ogawa; Masayuki Ohta; Shinichi Okazumi; Michio Shimabukuro; Iichiro Shimomura; Hitoshi Nishizawa; Atsuhito Saiki; Yosuke Seki; Nobuhiro Shojima; Motoyoshi Tsujino; Satoshi Ugi; Hiroaki Watada; Toshimasa Yamauchi; Takashi Yamaguchi; Kohjiro Ueki; Takashi Kadowaki; Ichiro Tatsuno
Journal:  Diabetol Int       Date:  2021-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.